| Medical and Health Sciences | Lifetime | 455 | US 249 | 99.98 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 13 | US 6 | 99.94 |
| Epidemiology | Lifetime | 439 | US 227 | 99.45 |
| Surgery | Lifetime | 599 | US 327 | 99.44 |
| Clinical Neurology | Lifetime | 716 | US 316 | 96.25 |
| Medical Genetics | Lifetime | 467 | US 237 | 95.65 |
| Reproductive Medicine | Lifetime | 800 | US 386 | 90.50 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 104 | US 54 | 98.51 |
| Epidemiology | 2021-2025 | 277 | US 96 | 97.78 |
| Surgery | 2021-2025 | 584 | US 226 | 95.10 |
| Clinical Neurology | 2021-2025 | 368 | US 146 | 88.36 |
| Pituitary Gland Disorders and Treatments | Lifetime | 1 | US 1 | 99.94 |
| Neuroendocrine Tumor Research Advances | Lifetime | 5 | US 3 | 99.91 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 10 | US 6 | 99.77 |
| Thyroid Cancer Diagnosis and Treatment | Lifetime | 6 | US 5 | 99.85 |
| Adrenal and Paraganglionic Tumors | Lifetime | 6 | US 3 | 99.85 |
| Neuroblastoma Research and Treatments | Lifetime | 16 | US 12 | 99.73 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 81 | US 40 | 99.67 |
| Fibroblast Growth Factor Research | Lifetime | 20 | US 12 | 99.35 |
| Glioma Diagnosis and Treatment | Lifetime | 82 | US 54 | 99.65 |
| Genetic factors in colorectal cancer | Lifetime | 147 | US 77 | 99.29 |
| Cancer-related Molecular Pathways | Lifetime | 211 | US 125 | 99.14 |
| Adrenal Hormones and Disorders | Lifetime | 86 | US 30 | 98.78 |
| Biomarkers in Disease Mechanisms | Lifetime | 64 | US 17 | 96.82 |
| Kruppel-like factors research | Lifetime | 122 | US 45 | 97.22 |
| Hormonal Regulation and Hypertension | Lifetime | 520 | US 220 | 97.71 |
| TGF-β signaling in diseases | Lifetime | 150 | US 78 | 97.15 |
| Lung Cancer Research Studies | Lifetime | 574 | US 250 | 97.99 |
| Genetic Syndromes and Imprinting | Lifetime | 224 | US 93 | 96.93 |
| Ovarian cancer diagnosis and treatment | Lifetime | 574 | US 265 | 97.72 |
| BRCA gene mutations in cancer | Lifetime | 377 | US 201 | 97.37 |
| Chromatin Remodeling and Cancer | Lifetime | 136 | US 76 | 95.99 |
| Soft tissue tumor case studies | Lifetime | 228 | US 118 | 96.91 |
| Head and Neck Anomalies | Lifetime | 169 | US 66 | 96.89 |
| Thyroid and Parathyroid Surgery | Lifetime | 316 | US 107 | 96.03 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 854 | US 360 | 95.32 |
| Parathyroid Disorders and Treatments | Lifetime | 978 | US 386 | 94.92 |
| Hedgehog Signaling Pathway Studies | Lifetime | 758 | US 359 | 91.80 |
| Gestational Trophoblastic Disease Studies | Lifetime | 696 | US 252 | 83.23 |
| Pituitary Gland Disorders and Treatments | 2021-2025 | 24 | US 5 | 98.85 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 42 | US 16 | 98.48 |
| Neuroblastoma Research and Treatments | 2021-2025 | 47 | US 16 | 97.82 |
| Adrenal and Paraganglionic Tumors | 2021-2025 | 39 | US 8 | 98.10 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 93 | US 17 | 94.82 |
| Thyroid Cancer Diagnosis and Treatment | 2021-2025 | 407 | US 99 | 91.65 |
| Lung Cancer Research Studies | 2021-2025 | 909 | US 272 | 90.12 |
| Head and Neck Anomalies | 2021-2025 | 178 | US 39 | 79.35 |
| Thyroid Disorders and Treatments | 2021-2025 | 790 | US 96 | 72.71 |
